Welcome to our dedicated page for Philip Morris news (Ticker: PM), a resource for investors and traders seeking the latest updates and insights on Philip Morris stock.
Philip Morris International (PM) maintains a dynamic presence in global markets through strategic initiatives and product evolution. This news hub provides investors and industry observers with essential updates about the company's financial performance, reduced-risk product developments, and regulatory engagements.
Access timely press releases and curated analysis covering PM's quarterly earnings, market expansion strategies, and innovations in smoke-free alternatives like heatsticks and oral nicotine products. Our repository simplifies tracking of critical milestones including acquisition announcements, sustainability efforts, and leadership changes impacting this tobacco industry leader.
All content undergoes rigorous verification to ensure accuracy and relevance for stakeholders monitoring PM's transition toward reduced-risk portfolios. Bookmark this page for streamlined access to operational updates and strategic disclosures from one of the world's largest publicly traded tobacco enterprises.
Philip Morris International (PM) has received commendations from CDP and Science Based Targets initiative (SBTi) for its sustainability initiatives. PMI is among only 10 companies globally to achieve a 'Triple A' from CDP over its climate change and water security efforts. Furthermore, SBTi has verified PMI's emissions targets, aligning them with the Paris Agreement goals. CEO André Calantzopoulos emphasized their commitment to sustainability, aiming for carbon neutrality in direct operations by 2030 and across the value chain by 2050. PMI's dedication to reducing environmental impact is highlighted through various strategic programs.
The FDA has authorized the sale of Philip Morris International's IQOS 3, an advanced electrically heated tobacco system, citing it as beneficial for public health. This decision follows a premarket tobacco product application submitted in March 2020. IQOS 3 features improved battery life and faster recharge times. The FDA reported no increased usage among youth and young adults. PMI's CEO stated that this approval could accelerate the transition from smoking to less harmful alternatives. The authorization is in line with previous PMTA orders aimed at minimizing unintended use among youth.
Philip Morris International (PMI) has joined The Valuable 500, a global initiative aimed at improving disability inclusion in business. CEO André Calantzopoulos emphasized that this commitment will not only enhance workplace diversity but also help the company tap into the talent of individuals with disabilities. PMI plans to establish a Global Employee Resource Group on Disability, improve accessibility in communication technologies, and address stigma around disability and mental health. This strategic move aligns with PMI's vision for a smoke-free future.
Philip Morris International Inc. (NYSE:PM) CFO Emmanuel Babeau addressed investors at the Morgan Stanley Virtual Global Consumer & Retail Conference. He revised the full-year 2020 reported diluted EPS forecast to approximately $5.08, slightly up from the previous range of $5.03 to $5.08. This revision reflects lower costs due to efficiencies and pandemic-related adjustments. The forecast suggests a 6% increase from the pro forma adjusted diluted EPS of $5.13 in 2019. Key assumptions include HTU shipment volumes of 75 to 76 billion units and market share gains in IQOS geographies.
Philip Morris International (PM) will hold a live video webcast featuring CFO Emmanuel Babeau at the Morgan Stanley Virtual Global Consumer & Retail Conference on December 2, 2020, starting at 10:00 a.m. ET. The session will be accessible via www.pmi.com/2020morganstanley, where presentation slides will also be available. An archived version of the webcast will remain online until December 31, 2020. PMI is committed to transitioning to a smoke-free future, with around 11.7 million adult smokers switching to its heat-not-burn product as of September 30, 2020.
Philip Morris Investments B.V., a subsidiary of Philip Morris International (PM), holds a one-third stake in Medicago, focusing on plant-derived vaccine development. Medicago has secured a deal with the Canadian government to supply 76 million doses of its COVID-19 vaccine, with C$173M ($131M) funding for its trials and manufacturing. PMI's CEO praised the collaboration to accelerate vaccine development. Medicago is currently advancing through clinical trials, with Phase 1 testing completed on July 14, and anticipates Phase 2 trials to start in November 2020.
Philip Morris International Inc. (NYSE:PM) reported its 2020 third-quarter results, highlighting a reported diluted EPS of $1.48, up 21.3%. Adjusted diluted EPS decreased by 0.7% to $1.42, while organic growth showed a 5.6% increase. Cigarette and heated tobacco volume shipments fell by 7.6%, but IQOS market share rose to 6.0%. Net revenues declined 2.6%, and operating income increased by 16.3%. The company raised its full-year diluted EPS guidance to $5.03-$5.08, driven by improved industry volumes and favorable tax effects. PMI assured no significant supply disruptions amid COVID-19.
Philip Morris International (NYSE: PM) will host a live audio webcast on October 20, 2020, at 9:00 a.m. ET to discuss its 2020 Third-Quarter results, which will be released at 7:00 a.m. ET the same day. CFO Emmanuel Babeau will provide insights and answer questions during the session, which will be accessible in listen-only mode. Investors can also access the webcast via PMI's Investor Relations Mobile App. The archived version will be available until November 18, 2020. PMI is transforming the tobacco industry, focusing on smoke-free products and aims to replace traditional cigarettes with healthier alternatives.
FAQ
What is the current stock price of Philip Morris (PM)?
What is the market cap of Philip Morris (PM)?
